Aramark Reports Earnings Results for Fiscal 2025

PHILADELPHIA--(BUSINESS WIRE)--Aramark (NYSE: ARMK) today reported results for the fourth quarter and full year of fiscal 2025. “Fiscal 2025 represented many consequential milestones for the Company, contributing to the strong growth trajectory ahead,” said John Zillmer, Aramark CEO. “In addition to being awarded one of the most prestigious medical systems in the world, we delivered almost $1 billion in Annualized Net New business, added more than $1 billion of new purchasing spend in our Globa